3 hemophilia patients lift uniQure’s value more than $450M
Shares in uniQure spiked Thursday morning as early clinical data showed hemophilia B patients injected with one of the biotech's gene therapies developed enough b...
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.